Doctor of Optometry Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Courtney Crowell

Optometrist Fort Worth, TX Doctor of Optometry

NPI 1295468866 CMS profile 11335854

655 Taylor St, Fort Worth, TX 76102

Open in the dashboard

General payments

$6,936

132 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Courtney Crowell of Fort Worth, TX is reported in the CMS Open Payments database as having received $6,936 across 132 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,104 39
2024 General $2,716 71
2023 General $1,093 21
2022 General $22 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Courtney Crowell
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Courtney Crowell were reported at $3,104. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Courtney Crowell Optometrist median Middle half National median
2019 $0 $159 $67–$371 $163
2020 $0 $72 $29–$165 $114
2021 $0 $125 $46–$292 $132
2022 $22 $162 $66–$374 $149
2023 $1,093 $177 $72–$406 $160
2024 $2,716 $188 $77–$427 $164
2025 $3,104 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. TissueTech, Inc. $2,025 18 payments
  2. RxSight Inc $982 12 payments
  3. Sun Pharmaceutical Industries Inc. $833 17 payments
  4. Bausch & Lomb Americas Inc. $517 18 payments
  5. AbbVie, Inc. $503 18 payments
  6. Glaukos Corporation $466 8 payments
  7. Harrow Eye, LLC $409 15 payments
  8. Tarsus Pharmaceuticals, Inc. $312 10 payments
  9. Dompe US, Inc. $266 3 payments
  10. Alcon Vision LLC $154 3 payments
  11. Other $468 10 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $6,149 131 payments
  2. Travel and Lodging $787 1 payment
Products named General payments · program years 2022–2025
  1. RXSIGHT LIGHT DELIVERY DEVICE (LDD) $982 12 payments
  2. RXSIGHT CONTACT LENS $982 12 payments
  3. RXSIGHT INJECTOR CARTRIDGE $982 12 payments
  4. RXSIGHT INJECTOR HANDPIECE $982 12 payments
  5. LIGHT ADJUSTABLE LENS (LAL) $949 11 payments
  6. Cequa $833 17 payments
  7. PROKERA $567 3 payments
  8. MIEBO $471 16 payments
  9. VEVYE $409 15 payments
  10. XDEMVY $312 10 payments
  11. Other $2,464 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

283

Median for Optometry: 120

Drug cost

$99,728

Median for Optometry: $8,864

Branded share of claims

54.1%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Restasis Cyclosporine Brand 67 $64,311
Miebo Perfluorohexyloctane/Pf Brand 15 $15,101
Lotemax Sm Loteprednol Etabonate Brand 32 $8,011
Cequa Cyclosporine Brand 11 $6,074
Prednisolone Acetate Generic 56 $2,982
Simbrinza Brinzolamide/Brimonidine Tart Brand 12 $2,546
Latanoprost Generic 29 $240
Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat Brand 16 $227
Brimonidine Tartrate Generic 23 $130
Timolol Maleate Generic 22 $105

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$73,797

Medicare's payments for the services billed

Medicare patients

301

Average age 73

Services billed

779

177 women, 124 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 42%
Diabetes 30%
Ischemic heart disease 29%
Chronic kidney disease 17%
Depression 17%
Atrial fibrillation 15%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 16 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Cequa
$420 11 —
VEVYE
$259 — —
XDEMVY
$234 — —
MIEBO
$205 15 —
DURYSTA
$144 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 16 in the dashboard with a free account

Records

132 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record